DalsnaFinance › Analyst accuracy › Morgan Stanley › AMGN target
Amgen (NASDAQ:AMGN) Rating Lowered to Hold at Wall Street Zen
Morgan Stanley dropped their price objective on shares of Amgen from $362.00 to $359.00 and set an "equal weight" rating for the company in a report on Wednesday.
A fact about what Morgan Stanley published, as reported by MarketBeat, not a recommendation from Dalsna Finance; Morgan Stanley is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.